Innovaderma Share Discussion Threads

[jonny_five111] 25/2/2020 09:45

Interesting that despite the dip in Roots sales, Boots have still doubled the shelf space dedicated to it. So theres still some positives. I agree the packaging needs work despite the product getting good reviews. Its pretty lacklustre.I'm surprised theres not been more mention of C+L which seems to be going from strength to strength and entering new markets. All in all, what with that and the new product launch and Skinny Tan delivering the goods and entering peak season, H2 looks good. Alot of the overheads for Nuthing are paid now so it's all about profit this next six months. I'm happy.

[rettah] 25/2/2020 09:37

Have to say I use roots but as a product find it really underwhelming. Sat on my shower tray next to Original Source shower gel the original source feels a better product and has better packaging, and it only costs £1. Hopefully the review of roots will address the basic issues with perception as the product in use seems pretty good.

[boonboon] 25/2/2020 09:33

£200k of marketing costs are for the new brand which obviously hasn't yet generated any sales.

[lord loads of lolly] 25/2/2020 09:22

muzmanoz - I agree with the broker re: Prolong revenue delay. Whilst today's statement anticipates ISO certification within the month, it also says "obtaining regulatory approvals is a long and arduous process". That, to me, is their get-out clause for when/if further delays occur. But this is largely a timing issue. The sales have already been agreed once approvals are obtained. My other main takeaways are: ST doing well (rollout into Tesco could be significant), Roots bombing, FY looking promising, but marketing costs needing close scrutiny. I know much of the increase in marketing costs is down to Boots rollout. But £1.7M on £5.1M sales. THAT'S A THIRD. Sounds high to me and is significantly up on LY, even if they've the margins to justify it.

[doc robinson] 25/2/2020 08:54

Should see director buys in next few days if they are confident of the future and do not forget the options at £1.20.

[connor23] 25/2/2020 08:52

All in agreement on the broker note then! Anyone who followed the stock knew the Roots forecast was completely bonkers. They seem to have swung the other way now! I think there is plenty of scope for ST to outperform. There is a question over the life sciences rev, but update did seem to address that and I look forward to confirmation on that next month (fingers crossed).

[muzmanoz] 25/2/2020 08:48

I agree tallprawn. Broker seems cautious.Looks like the broker doesnt expect the distribution agreements for prolong, and hence revenue recognition, to be finalised in H2.

[jonny_five111] 25/2/2020 08:41

I still think theres loose stock hanging around from HC sell. Taking opportunity of high liquidity. Still big round sells.

[gregpeck7] 25/2/2020 08:38

Things going well post hc.

[anony mous] 25/2/2020 08:36

As always, great update but the share price goes down.

[tallprawn] 25/2/2020 08:36

I can't say I agree with a lot of what's in that broker note to be honest. The growth attributed to ST for the remainder of this year looks completely wrong to me. The only thing I do agree with is the target price is a lot higher than the current share price

[boonboon] 25/2/2020 08:31

There's £400k in the forecast for nuthing. The big reduction is in Roots which was expected to see significant growth and is now expected to be flat.However overall I think the broker is being extremely cautious.

[muzmanoz] 25/2/2020 08:28

Strangely brokers note has reduced revenue by 7% and pbt by 9% and target price to 180p. Reflecting weaker roots expectations partially offset by Nuthing.

[mad foetus] 25/2/2020 08:27

My kill or fill at 74.1 for 5,000 shares got rejected. So I suspect there's no stock about and there is a big buyer in play

[matt] 25/2/2020 08:22

I believe previous forecasts do not include for Nuthing and there could be an uplift with success.

[mad foetus] 25/2/2020 08:21

HL really struggling with a piddling buy order

[boonboon] 25/2/2020 08:16

We don't have anything directly to do with China. Not sure where the components (bottles etc) come from. But I'm not too worried about that. We've got a massive inventory now so hopefully there's no need to panic about shortages.

[wskill] 25/2/2020 08:09

Thanks tall prawn/ muz that is good news seen Loreal was having problems with its supply chain glad there is no problems with IDP.

[tallprawn] 25/2/2020 08:08

Good time to enter. Lots of revenue drivers for H2 with another profitable full year performance ahead of us.

[mad foetus] 25/2/2020 08:06

I've bought a starter position here, gla

[tallprawn] 25/2/2020 07:56

Yes - All ST and Roots products are manufactured in the UK. No exposure to China. Likely the same for Nuthing also.

[wskill] 25/2/2020 07:53

Is manufacturing of products in Europe does anyone know .

[connor23] 25/2/2020 07:53

Another solid update for me. I feel we are on track to hit FY after that and I'm looking forward to an exciting few months with the Nuthing launch and NPD in the existing ranges. Combined with a strategy of deepening our relationships with key retailers and expanding the SKUs they stock I think we have set ourselves up well for the strong H2 we need.

[tallprawn] 25/2/2020 07:45

Big uplift in inventory also to £3.8m. That's why cash is down.. The business is well setup for a big H2.

[boonboon] 25/2/2020 07:39

And an additional 800 Boots stores.Plus qvc in the USA could be big as well.